Clinical Trial

Low-Dose Caffeine and Taurine Effects on Performance

Study acronym: CATAP
Completed
View on ClinicalTrials.gov →
Summary
This study aims to investigate the effects of low-dose caffeine and taurine, administered separately and in combination, on anaerobic, neuromuscular, and cognitive performance. The study is designed as a randomized, double-blind, placebo-controlled crossover trial involving trained man participants. Each participant will complete experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. Performance outcomes will include anaerobic power, neuromuscular performance, and cognitive function assessments. The findings will help clarify whether the combined ingestion of caffeine and taurine produces synergistic performance effects compared with isolated supplementation.
Trial Details
NCT Number NCT07466654
Lead Sponsor Ankara University
Collaborators: Burdur Mehmet Akif Ersoy University
Conditions Anaerobic Performance Neuromuscular Performance Cognitive Performance
Enrollment 32 participants
Start Date 2025-10-15
Primary Completion 2025-11-15 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-12